Bioreactor market size is likely to grow at a CAGR of over 18% from 2016 to 2023. PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Bioreactor market size is likely to grow at a CAGR of over 18% from 2016 to 2023.


1
Bioreactor Market Update 2016
2023
2
Global Market Scenario of Bioreactor Industry
Bioreactor market size is estimated to exceed USD
470 million by 2023 and is likely to grow at a
CAGR of over 18 from 2016 to 2023. Low
operational cost accompanied by minor requirement
for maintenance and monitoring compared to
traditional ones is anticipated to drive industry
demand. In addition, low energy consumption
coupled with simplicity in culturing of marine
microorganism namely algae is likely to propel
the industry demand for this system over the
several forthcoming years. Single use bioreactor
market size is likely to exceed USD 500 million
by 2023. Intense growth potential of biologics
industry is likely to offer massive growth
avenues to the industry participants over the
forecast period. Furthermore, lack of
availability of sterilized sensors is anticipated
to hider the industry growth. Low volume capacity
of these systems is likely to challenge the
industry demand for bioreactors from 2016 to 2023.
For more information please browse _at_
https//www.gminsights.com/request-toc/upcoming/14
1
3
Continue.....
The bioreactor market can be segmented on the
basis of product, molecule, cell, technology and
end use. On the basis of product type it can be
segregated as recombinant proteins and monoclonal
antibodies. Based on cell type, the industry can
be segmented into bacteria, mammalian cells as
well as yeast. Mammalian cells are anticipated to
be the fastest and largest growing in the
industry. On the basis of technology the
industry can be segmented into wave-induced
motion SUB, stirred SUB and single use bubble
column bioreactor. Wave-induced motion SUB sector
is anticipated to account for the major share and
is expected to grow at the highest rate over the
forecast period. On the basis of molecule the
industry can be segregated into vaccines,
monoclonal antibodies (MAbs), gene therapy,
recombinant proteins and stem cells Vendors are
anticipated to expand the range of options
offered along with the flexibility of systems,
facilitating users to experiment with different
amalgamations of bioprocessing components.
Proliferating RD through commercial production
and pilot-scale, mixing matching systems in
order to find the best solution for a particular
application is expected to fuel the industry over
the several upcoming years.  
Read more at _at_ https//www.gminsights.com/industry
-analysis/bioreactor-market F
4

Request for an in-depth table of contents for
this report _at_ https//www.gminsights.com/request-t
oc/upcoming/141 Latest Research Report
Bioreactor Market_at_ https//www.gminsights.com/indu
stry-analysis/bioreactor-market
5
Thank you
You can visit us at www.gminsights.com
Write a Comment
User Comments (0)
About PowerShow.com